Hybrigenics Acquires Dualsystems Biotech's Yeast Two-Hybrid Business | GenomeWeb

NEW YORK (GenomeWeb News) – Hybrigenics has acquired the yeast two-hybrid assets of Swiss biotech firm Dualsystems Biotech.

The acquisition provides Hybrigenic Services, a subsidiary of Paris-based biopharma firm Hybrigenics that specializes in protein-protein interaction work, with exclusive ownership of patented yeast two-hybrid screening technology for membrane proteins. The deal will expand the company's commercial reach in German-speaking territories, Eastern Europe, and China, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."